Fast Facts: Treatment-Free Remission in Chronic Myeloid Leukemia : From concept to practice and beyond
The tyrosine kinase inhibitor (TKI) imatinib was the first treatment to specifically target cancer cells, rather than the relatively indiscriminate effects of conventional chemotherapy on any rapidly dividing cells. This concept of targeted treatment in cancer is one of the important advances in mod...
Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | Livre numérique |
| Langue: | Anglais |
| Publié: |
Basel :
S. Karger
2020.
Basel : |
| Accès en ligne: | https://www.karger.com/Book/Home/280561 Accès Université d'Orléans et IFPM |
| Note: |
Karger Fast Facts |
| Autres localisations: | Voir dans le Sudoc |